Acadia Pharmaceuticals buy Needham & Company LLC
Start price
12.03.24
/
50%
€18.20
Target price
12.03.25
€29.32
Performance (%)
-19.67%
Price
05.09.24
€14.62
Summary
This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -19.67%. This prediction currently runs until 12.03.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | - | - |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Needham & Company LLC from $36.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€13.74
07.08.24
07.08.24
€25.63
07.08.25
07.08.25
4.66%
05.09.24
05.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.02
09.05.24
09.05.24
€27.88
09.05.25
09.05.25
-2.63%
05.09.24
05.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.56
09.04.24
09.04.24
€29.40
09.04.25
09.04.25
-12.59%
05.09.24
05.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-32.31%
05.09.24
05.09.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.80
24.01.24
24.01.24
€33.86
24.01.25
24.01.25
-41.65%
05.09.24
05.09.24